VSee Health receives Nasdaq bid price deficiency letter; faces multiple listing non-compliance issues

VSEE HEALTH, INC.

Nasdaq staff notified VSee on Sep 24, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until March 23, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
Also not in compliance with timely filing of Q1 and Q2 2025 10-Qs and minimum stockholders' equity of $2.5M.
Company intends to monitor bid price and consider options, including a potential reverse stock split.
If not cured, VSee's common stock and public warrants may be delisted from Nasdaq.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.